| PERIOD ENDING | 30-Apr-09 | 30-Apr-08 | 30-Apr-07 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue | 1,150 |
-
| 9,216 | | | Gross Profit | (1,150) |
-
| (9,216) | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 4,300 | 10,758 | 4,988 | | Non Recurring |
-
|
-
|
-
| | Others | 265 | 152 | 39 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (5,714) | (10,909) | (14,244) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,753) | (12,974) | 942 | | Earnings Before Interest And Taxes | (13,467) | (23,883) | (13,302) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (13,467) | (23,883) | (13,302) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,467) | (23,883) | (13,302) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (13,467) | (23,883) | (13,302) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,467) | ($23,883) | ($13,302) |
|
0.83% Nasdaq 
Income Statement
